title: Antibacterial research and development in the 21(st) Century--an industry perspective of the challenges.
authors.affiliation: Bayer plc, Hunton House, Oxford Road, Uxbridge, UB8 IHU Middlesex, UK. chris.thomson.ct@bayer.co.uk
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Thomson
authors.forename: Edward
authors.initials: E
authors.lastname: Power
authors.forename: Helga
authors.initials: H
authors.lastname: Ruebsamen-Waigmann
authors.forename: Harald
authors.initials: H
authors.lastname: Labischinski
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001424:Bacterial Infections / Q000188:drug therapy*; D004353:Drug Evaluation, Preclinical / Q000191:economics / Q000379:methods* / Q000639:trends*; D004345:Drug Industry / Q000191:economics / Q000639:trends; D024881:Drug Resistance, Bacterial; D006801:Humans; D012106:Research / Q000639:trends
chemical_list: D000900:Anti-Bacterial Agents